Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Investig Med High Impact Case Rep ; 10: 23247096221089488, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35403472

RESUMO

Primary biliary cholangitis (PBC) is a rare autoimmune disease characterized by intralobular bile duct destruction. Patients typically present with generalized symptoms including fatigue and pruritis, and less commonly, manifestations of lipid deposition including xanthomas and xanthelasmas. We report a case of a 31-year-old female with PBC-associated cirrhosis who had cutaneous xanthelasmas and diffuse gastric xanthomas secondary to hyperlipidemia and lipoprotein X that completely resolved following liver transplantation. While gastric xanthomas have been reported in patients with PBC previously, to our knowledge, this is the first case report of diffuse gastric xanthomas secondary to PBC reported to resolve following liver transplantation, suggesting that liver transplantation is curative for gastric xanthomatosis in patients with PBC-related cirrhosis.


Assuntos
Colangite , Cirrose Hepática Biliar , Xantomatose , Adulto , Autoanticorpos , Colangite/diagnóstico , Feminino , Humanos , Lipoproteína-X , Cirrose Hepática Biliar/complicações , Xantomatose/etiologia
2.
Clin Liver Dis ; 24(1): 89-106, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31753253

RESUMO

Drug-induced liver injury (DILI) is an uncommon but significant cause of liver injury and need for liver transplant. DILI in the setting of chronic liver disease (CLD) is poorly understood. Clinical features of patients presenting with DILI in the setting of CLD are similar to those without CLD with the exception of a higher incidence of diabetes among those with CLD and DILI. Diagnosis of DILI in CLD is difficult because there are no objective biomarkers and current causality assessments have not been studied in this population. Differentiating DILI from exacerbation of underlying liver disease is even more challenging.


Assuntos
Insuficiência Hepática Crônica Agudizada , Doença Hepática Induzida por Substâncias e Drogas , Progressão da Doença , Doença Hepática Terminal , Insuficiência Hepática Crônica Agudizada/diagnóstico , Insuficiência Hepática Crônica Agudizada/epidemiologia , Doença Hepática Induzida por Substâncias e Drogas/diagnóstico , Doença Hepática Induzida por Substâncias e Drogas/epidemiologia , Diagnóstico Diferencial , Doença Hepática Terminal/diagnóstico , Doença Hepática Terminal/epidemiologia , Humanos , Análise de Mediação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA